Autophagy Impacts on Oxaliplatin-induced Hepatocarcinoma Apoptosis Via the IL-17/IL-17R-JAK2/STAT3 Signaling Pathway

Overview

Journal Oncol Lett

Specialty Oncology

Date 2017 Mar 31

PMID 28356957

Citations 20

Authors

Jinghua Wu

Jiapei Guo

Qing Cao

Yi Wang

Junmao Chen

Zhigang Wang

Zhiyong Yuan

Affiliations

Soon will be listed here.

Abstract

The interleukin (IL)-17/IL-17 receptor (IL-17R) complex has been shown to be important for the regulation of inflammation; however, its role in the regulation of tumor processes has recently emerged as a research focus. The present study demonstrated that oxaliplatin was able to increase the levels of IL-17/IL-17R in hepatocellular carcinoma (HCC) patients and cells lines, and that it had important roles in reducing the susceptibility of the cells to oxaliplatin-induced apoptosis. Furthermore, the expression of autophagy-related proteins was induced by IL-17/IL-17R and autophagy was shown to induce resistance to oxaliplatin in HCC. In addition, the janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway was shown to be an important pathway in the induction of autophagy in response to oxaliplatin. Autopjhagy was inhibited by 3-methyladenine and JAK2/STAT3 signaling was blocked by AG490, which induced apoptosis in SMMC7721 cells treated with oxaliplatin. The results of the present study may help to elucidate the mechanism underlying the role of IL-17/IL-17R-induced autophagy in the chemoresistance of HCC, as well as help to establish and develop measures to overcome chemoresistance in HCC.

Citing Articles

Impact of STAT-signaling pathway on cancer-associated fibroblasts in colorectal cancer and its role in immunosuppression.

Sanchez-Ramirez D, Mendoza-Rodriguez M, Aleman O, Candanedo-Gonzalez F, Rodriguez-Sosa M, Montesinos-Montesinos J World J Gastrointest Oncol. 2024; 16(5):1705-1724.

PMID: 38764833 PMC: 11099434. DOI: 10.4251/wjgo.v16.i5.1705.

Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy.

Wu T, Zheng Z, Wang J, He M, Wang J, Pan Y J Hepatocell Carcinoma. 2023; 10:2133-2145.

PMID: 38058386 PMC: 10697146. DOI: 10.2147/JHC.S437329.

Circulating IL-17 reduces the risk of cisplatin-induced hearing loss in children: a bidirectional two-sample Mendelian randomization study.

Xu Y, Huang C, Liu J, Xu Y, Yang H Sci Rep. 2023; 13(1):18957.

PMID: 37919361 PMC: 10622445. DOI: 10.1038/s41598-023-46299-2.

The IL-17 family in diseases: from bench to bedside.

Huangfu L, Li R, Huang Y, Wang S Signal Transduct Target Ther. 2023; 8(1):402.

PMID: 37816755 PMC: 10564932. DOI: 10.1038/s41392-023-01620-3.

Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications.

Park H, Lee S, Lee J, Moon H, Ro S Int J Mol Sci. 2023; 24(18).

PMID: 37762066 PMC: 10531214. DOI: 10.3390/ijms241813764.

References

Huang F, Kao C, Wachi S, Thai P, Ryu J, Wu R . Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. J Immunol. 2007; 179(10):6504-13. DOI: 10.4049/jimmunol.179.10.6504. View

Martin F, Apetoh L, Ghiringhelli F . Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?. Trends Mol Med. 2012; 18(12):742-9. DOI: 10.1016/j.molmed.2012.09.007. View

Ma Y, Aymeric L, Locher C, Mattarollo S, Delahaye N, Pereira P . Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J Exp Med. 2011; 208(3):491-503. PMC: 3058575. DOI: 10.1084/jem.20100269. View

Huang C, Yang G, Jiang T, Huang K, Cao J, Qiu Z . Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro. J Exp Clin Cancer Res. 2010; 29:51. PMC: 2883975. DOI: 10.1186/1756-9966-29-51. View

Zhang J, Yan J, Xu J, Pang X, Chen M, Li L . Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol. 2009; 50(5):980-9. DOI: 10.1016/j.jhep.2008.12.033. View

Xu Y, An Y, Wang Y, Zhang C, Zhang H, Huang C . miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells. Oncol Rep. 2013; 29(5):2019-24. DOI: 10.3892/or.2013.2338. View

Lv L, Pan K, Li X, She K, Zhao J, Wang W . The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma. PLoS One. 2011; 6(3):e18219. PMC: 3069054. DOI: 10.1371/journal.pone.0018219. View

Zou W, Restifo N . T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol. 2010; 10(4):248-56. PMC: 3242804. DOI: 10.1038/nri2742. View

Gu F, Li Q, Gao Q, Jiang J, Zhu K, Huang X . IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Mol Cancer. 2011; 10:150. PMC: 3310750. DOI: 10.1186/1476-4598-10-150. View

10.

Sun X, Zhang J, Hou Z, Han Q, Zhang C, Tian Z . miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression. Cell Cycle. 2015; 14(2):243-52. PMC: 4352959. DOI: 10.4161/15384101.2014.977112. View

11.

Li J, Yang D, Wang W, Piao S, Zhou J, Saiyin W . Inhibition of autophagy by 3-MA enhances IL-24-induced apoptosis in human oral squamous cell carcinoma cells. J Exp Clin Cancer Res. 2015; 34:97. PMC: 4567787. DOI: 10.1186/s13046-015-0211-0. View

12.

Shpilka T, Weidberg H, Pietrokovski S, Elazar Z . Atg8: an autophagy-related ubiquitin-like protein family. Genome Biol. 2011; 12(7):226. PMC: 3218822. DOI: 10.1186/gb-2011-12-7-226. View

13.

Gaffen S . Recent advances in the IL-17 cytokine family. Curr Opin Immunol. 2011; 23(5):613-9. PMC: 3190066. DOI: 10.1016/j.coi.2011.07.006. View

14.

Tan Y, Zhang J, Zhou G . Autophagy and its implication in human oral diseases. Autophagy. 2016; 13(2):225-236. PMC: 5324841. DOI: 10.1080/15548627.2016.1234563. View

15.

Cui J, Gong Z, Shen H . The role of autophagy in liver cancer: molecular mechanisms and potential therapeutic targets. Biochim Biophys Acta. 2013; 1836(1):15-26. DOI: 10.1016/j.bbcan.2013.02.003. View

16.

Weiland A, Roswall P, Hatzihristidis T, Pietras K, Ostman A, Strell C . Fibroblast-dependent regulation of the stem cell properties of cancer cells. Neoplasma. 2012; 59(6):719-27. DOI: 10.4149/neo_2012_091. View

17.

Shen F, Gaffen S . Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine. 2008; 41(2):92-104. PMC: 2667118. DOI: 10.1016/j.cyto.2007.11.013. View

18.

Sun H, Zhang J, Zhang H, Zou Z, Wang F, Jia J . Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J Viral Hepat. 2012; 19(6):396-403. DOI: 10.1111/j.1365-2893.2011.01561.x. View

19.

Novatchkova M, Leibbrandt A, Werzowa J, Neubuser A, Eisenhaber F . The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem Sci. 2003; 28(5):226-9. DOI: 10.1016/S0968-0004(03)00067-7. View

20.

Xu Y, Lv S . The effect of JAK2 knockout on inhibition of liver tumor growth by inducing apoptosis, autophagy and anti-proliferation via STATs and PI3K/AKT signaling pathways. Biomed Pharmacother. 2016; 84:1202-1212. DOI: 10.1016/j.biopha.2016.09.040. View